Davis T. Weaver

755 total citations · 1 hit paper
14 papers, 361 citations indexed

About

Davis T. Weaver is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Davis T. Weaver has authored 14 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Davis T. Weaver's work include Colorectal Cancer Screening and Detection (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Evolution and Genetic Dynamics (3 papers). Davis T. Weaver is often cited by papers focused on Colorectal Cancer Screening and Detection (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Evolution and Genetic Dynamics (3 papers). Davis T. Weaver collaborates with scholars based in United States, Australia and Austria. Davis T. Weaver's co-authors include Pari V. Pandharipande, Anna P. Lietz, Amy B. Knudsen, Peter P. Mueller, Sarah Mercaldo, Marc R. Larochelle, Kenneth A. Freedberg, Qiushi Chen, Sarah E. Wakeman and Jagpreet Chhatwal and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Radiology and International Journal of Molecular Sciences.

In The Last Decade

Davis T. Weaver

13 papers receiving 352 citations

Hit Papers

Prevention of Prescription Opioid Misuse and Projected Ov... 2019 2026 2021 2023 2019 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Davis T. Weaver United States 9 167 88 79 55 55 14 361
Jessica Ma United States 9 172 1.0× 56 0.6× 63 0.8× 44 0.8× 54 1.0× 53 440
Wenwu Cheng China 11 158 0.9× 82 0.9× 27 0.3× 35 0.6× 36 0.7× 24 310
Shapei Yan United States 10 152 0.9× 75 0.9× 85 1.1× 7 0.1× 28 0.5× 25 297
Neeraj Chhabra United States 9 81 0.5× 77 0.9× 40 0.5× 23 0.4× 17 0.3× 37 285
David Hui United States 9 60 0.4× 128 1.5× 78 1.0× 57 1.0× 38 0.7× 10 454
Andrew Taylor United States 11 33 0.2× 96 1.1× 114 1.4× 30 0.5× 22 0.4× 22 320
Yingkai Cheng United States 7 90 0.5× 82 0.9× 108 1.4× 16 0.3× 39 0.7× 13 267
Siavash Moradi Iran 9 46 0.3× 28 0.3× 28 0.4× 28 0.5× 21 0.4× 46 324
Elizabeth Pršić United States 11 70 0.4× 81 0.9× 18 0.2× 53 1.0× 40 0.7× 43 276
Behnam Reza Makhsosi Iran 12 32 0.2× 146 1.7× 53 0.7× 69 1.3× 11 0.2× 17 377

Countries citing papers authored by Davis T. Weaver

Since Specialization
Citations

This map shows the geographic impact of Davis T. Weaver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davis T. Weaver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davis T. Weaver more than expected).

Fields of papers citing papers by Davis T. Weaver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davis T. Weaver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davis T. Weaver. The network helps show where Davis T. Weaver may publish in the future.

Co-authorship network of co-authors of Davis T. Weaver

This figure shows the co-authorship network connecting the top 25 collaborators of Davis T. Weaver. A scholar is included among the top collaborators of Davis T. Weaver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davis T. Weaver. Davis T. Weaver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Weaver, Davis T., et al.. (2025). Fitness seascapes are necessary for realistic modeling of the evolutionary response to drug therapy. Science Advances. 11(24). eadv1268–eadv1268.
2.
Weaver, Davis T., et al.. (2024). Cell-cell fusion in cancer: The next cancer hallmark?. The International Journal of Biochemistry & Cell Biology. 175. 106649–106649. 5 indexed citations
3.
Weaver, Davis T., et al.. (2024). Reinforcement learning informs optimal treatment strategies to limit antibiotic resistance. Proceedings of the National Academy of Sciences. 121(16). e2303165121–e2303165121. 10 indexed citations
4.
Weaver, Davis T., et al.. (2023). Evolution-Informed Strategies for Combating Drug Resistance in Cancer. International Journal of Molecular Sciences. 24(7). 6738–6738. 8 indexed citations
5.
Weaver, Davis T., et al.. (2023). Graph ‘texture’ features as novel metrics that can summarize complex biological graphs. Physics in Medicine and Biology. 68(17). 174001–174001. 1 indexed citations
6.
Weaver, Davis T., Kathleen I. Pishas, Drew F. K. Williamson, et al.. (2021). Network potential identifies therapeutic miRNA cocktails in Ewing sarcoma. PLoS Computational Biology. 17(10). e1008755–e1008755. 9 indexed citations
7.
Weaver, Davis T., Emily Dolson, Nikhil Krishnan, et al.. (2020). UV-C tower for point-of-care decontamination of filtering facepiece respirators. American Journal of Infection Control. 49(4). 424–429. 16 indexed citations
8.
Weaver, Davis T., Anna P. Lietz, Sarah Mercaldo, et al.. (2019). Testing for Verification Bias in Reported Malignancy Risks for Side-Branch Intraductal Papillary Mucinous Neoplasms: A Simulation Modeling Approach. American Journal of Roentgenology. 212(3). 596–601. 6 indexed citations
9.
Chen, Qiushi, Marc R. Larochelle, Davis T. Weaver, et al.. (2019). Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States. JAMA Network Open. 2(2). e187621–e187621. 205 indexed citations breakdown →
10.
Weaver, Davis T., Alexander Melamed, J. Alejandro Rauh‐Hain, et al.. (2018). Modeling treatment outcomes for patients with advanced ovarian cancer: Projected benefits of a test to optimize treatment selection. Gynecologic Oncology. 149(2). 256–262. 6 indexed citations
11.
Peters, Mary Linton B., Peter P. Mueller, Angela C. Tramontano, et al.. (2018). Progression to pancreatic ductal adenocarcinoma from pancreatic intraepithelial neoplasia: Results of a simulation model. Pancreatology. 18(8). 928–934. 43 indexed citations
12.
Weaver, Davis T., Anna P. Lietz, Efrén J. Flores, et al.. (2018). Patient Navigation to Improve Cancer Screening in Underserved Populations: Reported Experiences, Opportunities, and Challenges. Journal of the American College of Radiology. 15(11). 1565–1572. 29 indexed citations
13.
Criss, Steven D., Davis T. Weaver, Deirdre F. Sheehan, et al.. (2018). Effect of PD-L1 testing on the cost-effectiveness and budget impact of pembrolizumab for advanced urothelial carcinoma of the bladder in the United States. Urologic Oncology Seminars and Original Investigations. 37(3). 180.e11–180.e18. 15 indexed citations
14.
Weaver, Davis T., Lincoln L. Berland, Brian R. Herts, et al.. (2018). Imaging Follow-up of Low-Risk Incidental Pancreas and Kidney Findings: Effects of Patient Age and Comorbidity on Projected Life Expectancy. Radiology. 287(2). 504–514. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026